Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$65.20 0.74 (1.12%) as of 4:30 Tue 4/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 81.50(B)
Last Volume: 7,436,599 Avg Vol: 8,754,576
52 Week Range: $65.27 - $87.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  259
Guru Rank Value     : 4.6
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 12,230 25,472 38,458 80,792
Total Sell Value $890,904 $2,022,270 $3,052,046 $6,445,296
Total People Sold 1 3 3 4
Total Sell Transactions 3 5 9 14
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 2493
  Page 9 of 100  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Oday Daniel Patrick Chairman & CEO   •       •      –    2022-01-26 4 A $0.00 $0 D/D 146,678 239,187     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-01-26 4 D $67.34 $243,501 D/D (3,616) 58,656     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2022-01-26 4 A $0.00 $0 D/D 32,176 62,272     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-01-26 4 D $67.34 $26,532 D/D (394) 22,875     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2022-01-26 4 A $0.00 $0 D/D 2,871 23,269     -
   Parsey Merdad Chief Medical Officer   •       •      –    2022-01-26 4 A $0.00 $0 D/D 20,298 37,158     -
   Bluestone Jeffrey Director   •       •      –    2021-12-08 4 OE $0.00 $0 D/D 1,041 1,041     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2021-11-10 4 D $67.32 $58,568 D/D (870) 38,015     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2021-11-10 4 OE $0.00 $0 D/D 1,913 38,885     -
   Parsey Merdad Chief Medical Officer   •       •      –    2021-11-10 4 D $67.32 $156,182 D/D (2,320) 16,860     -
   Parsey Merdad Chief Medical Officer   •       •      –    2021-11-10 4 OE $0.00 $0 D/D 5,100 19,180     -
   Welters Anthony Director   •       •      –    2021-10-22 4 OE $0.00 $0 D/D 1,368 1,368     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-08-17 4 S $72.50 $986,725 D/D (13,610) 20,398 0%     
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-08-17 4 OE $66.36 $926,536 D/D 13,610 34,008     -
   Pletcher Brett A EVP,Corp Affairs & Gen Counsel   •       •      –    2021-08-15 4 A $55.08 $1,763 D/D 32 29,198     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2021-08-15 4 A $55.08 $55 D/D 1 36,972     -
   Parsey Merdad Chief Medical Officer   •       •      –    2021-08-15 4 A $55.08 $55 D/D 1 14,080     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-08-10 4 D $69.24 $62,801 D/D (907) 20,398     -
   Wilfong Diane E SVP, Controller & CAO   •       •      –    2021-08-10 4 OE $0.00 $0 D/D 2,480 21,305     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2021-07-24 4 D $69.02 $236,394 D/D (3,425) 12,148     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2021-07-24 4 OE $0.00 $0 D/D 7,505 15,573     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2021-06-10 4 D $69.29 $111,210 D/D (1,605) 36,971     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2021-06-10 4 OE $0.00 $0 D/D 3,646 38,576     -
   Manwani Harish Director   •       •      –    2021-05-06 4 OE $0.00 $0 D/D 1,936 5,654     -
   Whitley Richard James Director   •       •      –    2021-05-06 4 OE $0.00 $0 D/D 1,936 33,058     -
  2493 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 100
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us